BIOVANTAGE.DK ApS: Financial statements 2023
CVR: 36498544
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
BIOVANTAGE.DK ApS (CVR 36498544) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -243,628 and a net result of DKK -612,916 compared with DKK -264,925 the year before. Equity in the 2023 report amounted to DKK -5,792,487.
- Gross Profit
- DKK -243,628
- Profit/Loss
- DKK -612,916
- Equity
- DKK -5,792,487
- Total Assets
- DKK 6,850,367
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -244 t. | -613 t. | -5.8 mio. | 0 |
| 2022 | - | -94 t. | -265 t. | -5.2 mio. | 1 |
| 2021 | - | 4.1 mio. | 2.1 mio. | -4.9 mio. | 2 |
| 2020 | - | 3.3 mio. | -1.1 mio. | -7 mio. | 2 |
| 2019 | - | 2.7 mio. | -1.9 mio. | -5.9 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 14, 2023, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of BIOVANTAGE.DK ApS.
As of December 14, 2023, A/S PSE 17 NR. 1056 has stepped down as auditor of BIOVANTAGE.DK ApS.
About BIOVANTAGE.DK ApS
BIOVANTAGE.DK ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company has been dissolved on 30 December 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2021). In 2023, the company reported a gross profit of DKK -243,628 and a net result of DKK -612,916 compared with DKK -264,925 the year before. Equity in the 2023 report amounted to DKK -5,792,487.